Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
01 1Supriya Lifescience Limited
02 1Moehs Catalana SL
03 1Arevipharma GmbH
04 1Aurobindo Pharma Limited
05 1Harman Finochem Limited
06 1Ipca Laboratories Limited
07 1MEDISCA Inc.
08 1Merck & Cie
09 1Piramal Pharma Limited
10 1Unichem Laboratories Limited, India
01 1BISOPROLOL FUMARATE
02 7Bisoprolol Fumarate
03 1Bisoprolol Hemifumarate
04 1Bisoprolol fumarate
01 1Germany
02 5India
03 1Spain
04 1Switzerland
05 2U.S.A
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-5250
Start Marketing Date : 2022-07-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0720
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10920-571
Start Marketing Date : 2010-11-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-380
Start Marketing Date : 2023-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66064-1004
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1192
Start Marketing Date : 2010-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3142
Start Marketing Date : 2019-05-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54784-027
Start Marketing Date : 2015-08-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65085-0051
Start Marketing Date : 2015-05-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-009
Start Marketing Date : 2003-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bisoprolol Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bisoprolol Fumarate, including repackagers and relabelers. The FDA regulates Bisoprolol Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bisoprolol Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bisoprolol Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bisoprolol Fumarate supplier is an individual or a company that provides Bisoprolol Fumarate active pharmaceutical ingredient (API) or Bisoprolol Fumarate finished formulations upon request. The Bisoprolol Fumarate suppliers may include Bisoprolol Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Bisoprolol Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bisoprolol Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bisoprolol Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bisoprolol Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bisoprolol Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bisoprolol Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bisoprolol Fumarate suppliers with NDC on PharmaCompass.
We have 10 companies offering Bisoprolol Fumarate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
